const consentListeners = []; window.ConsentListener = (callback) => { consentListeners.push(callback); }; const onConsentChange = (consent) => { consentListeners.forEach((callback) => { callback(consent); }); };

Partners and Projects

AWARDED EUROPEAN GRANTS

  • REASON: Regenerating the diabetic heart and kidney by using stress-specific thyroid hormone nanocarriers
  • SBR: Smart Bone Regeneration - Novel Regeneration Techniques for Large Bone Defects
  • cmRNAbone: 3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients - A novel Gene Therapy for Bone Regeneration
  • LIQD-CORNEA: A liquid corneal glue-filler as an alternative to transplantation in high-risk patients. EuroNanoMed III
  • MODIFY-NK: A novel modified natural killer (NK) cell immunotherapy for the treatment of solid tumours. Eurostars.
    More information
  • UNIVAX: A "Universal" Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines. FP-7 (HEALTH-F3-2013-601738) 
  • GAMBA: Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis. FP7 (NMP3-SL-2010-245993)
  • CLINIGENE: European Network for the advancement of Clinical Gene Transfer & Therapy. FP6 (LSHB-CT-2006-018933)
  • EPICURE: Functional genomics and neurobiology of epilepsy: a basis for new therapeutic strategies. FP6 (LSHM-CT-2006-037315)
  • MAGSELECTOFECTION: Combined isolation and stable non-viral transfection of hematopoietic cells – a novel platform technology for ex vivo hematopoietic stem cell gene therapy. FP6 (LSHB-CT-2006-019038)
  • IMPROVED PRECISION: Improved precision of nucleic acid based therapy of cystic fibrosis. FP6 (LSHB-CT-2004-005213)

Marie Skłodowska-Curie Actions - MSCA

  • OcuTher: Educational Network in Ocular Drug Delivery and Therapeutics - This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 722717.
  • NANOMED: “Nanomedicine: an integrative approach”. MARIE SKŁODOWSKA-CURIE ACTIONS HEALTH, H2020-MSCA-ITN-2015.

SCIENTIFIC PARTNER

 

BUSINESS & FINANCIAL PARTNERS

INSTITUTIONAL PARTNERS